Tod Steinfeld - Concepedia

Author

Tod Steinfeld

Theravance Biopharma (United States)

Also Known As

T Steinfeld, T. Steinfeld, Tod Steinfeld

Publications

482

Citations

H-Index

Concepts

All Affiliations

Theravance Biopharma (United States)Reset Therapeutics

About

Tod Steinfeld is an author at Theravance Biopharma (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	240
2	Pharmacology	7	7	240
3	Biochemistry	3	3	141
4	Natural Sciences	2	2	122
5	Pulmonary Medicine	1	1	34

Tod Steinfeld

Publications

430

Citations

H-Index

Page 1

	Year	Citations
A Novel Multivalent Ligand That Bridges the Allosteric and Orthosteric Binding Sites of the M2 Muscarinic Receptor Tod Steinfeld, Mathai Mammen, Jacqueline A.M. Smith, Molecular Pharmacology	2007	93
Carbazole-containing sulfonamides and sulfamides: Discovery of cryptochrome modulators as antidiabetic agents Paul S. Humphries, Ross Bersot, John Kincaid, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ChemistryPharmaceutical ScienceBiochemistryMedicine	2015	73
Carbazole-containing amides and ureas: Discovery of cryptochrome modulators as antihyperglycemic agents Paul S. Humphries, Ross Bersot, John Kincaid, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesCryptochrome Modulators	2017	49
THRX-198321 Is a Bifunctional Muscarinic Receptor Antagonist and β2-Adrenoceptor Agonist (MABA) That Binds in a Bimodal and Multivalent Manner Tod Steinfeld, Adam D. Hughes, Uwe Klein, Molecular Pharmacology	2010	42
Discovery of (<i>R</i>)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1′-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and β<sub>2</sub> Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) Adam D. Hughes, Yan Chen, Sharath S. Hegde, Journal of Medicinal Chemistry Linker MotifLung InflammationPharmacotherapySystem PharmacologyPre-clinical Pharmacology	2015	34
Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules Adam D. Hughes, Kay H. Chin, Sarah L. Dunham, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicineBeta 2PhysiologyMechanism Of Action	2011	32
Pharmacological properties of revefenacin (<scp>TD</scp>‐4208), a novel, nebulized long‐acting, and lung selective muscarinic antagonist, at human recombinant muscarinic receptors and in rat, guinea pig, and human isolated airway tissues Sharath S. Hegde, M. Teresa Pulido‐Rios, Mark A. Luttmann, Pharmacology Research & Perspectives	2018	26
Muscarinic receptor subtypes and signalling involved in the attenuation of isoprenaline-induced rat urinary bladder relaxation Lambertus P. W. Witte, Noach de Haas, Mathai Mammen, Naunyn-Schmiedeberg s Archives of Pharmacology Synaptic TransmissionAnesthetic MechanismPharmacotherapyExperimental PharmacologyMolecular Pharmacology	2011	19
A multivalent approach towards linked dual-pharmacology prostaglandin F receptor agonist/carbonic anhydrase-II inhibitors for the treatment of glaucoma Daniel D. Long, Bryan A. Frieman, Sharath S. Hegde, Bioorganic & Medicinal Chemistry Letters BiochemistryMultivalent Approach TowardsMedicineG Protein-coupled ReceptorMechanism Of Action	2012	19
Pharmacologic Characterization of GSK-961081 (TD-5959), a First-in-Class Inhaled Bifunctional Bronchodilator Possessing Muscarinic Receptor Antagonist and β2-Adrenoceptor Agonist Properties Sharath S. Hegde, Adam D. Hughes, Yan Chen, Journal of Pharmacology and Experimental Therapeutics	2014	17

Page 1